The rheumatism arthritis (RA) is a chronic, whole-of-the-body autoimmune disease that is mainly clinically manifested by osmosis and symmetrical multiple arthritis, which seriously affects the function and quality of life of patients. As a biological agent, ATM plays an important role in the treatment of rheumatism arthritis, but its use requires the improvement of the relevant examinations and of the standard treatment process, as described below.
Use Adawood to fight ahead.
General medical examination
Doctors are required to carry out a full medical examination of patients, with a focus on arthropodic stress, such as observation of the swelling, pain and deformity of the joints, recording of the range of activities of the joints, and understanding of the duration of the morning rigidity, so as to determine the stage of the disease, and to establish a base comparison for subsequent evaluation of the effectiveness of the treatment. Like a finger joint, see if there is a swollen swollen swollen, wrist joints, knee joints, etc.
Laboratory inspection
General blood testing: including blood routines, looking at white cells, red cells, slab count, since rheumatism itself may cause abnormalities in the blood system, while some patients may have adverse effects on blood cells following the use of the Adam stand alone, so that the base values are clear. In addition, blood sunk (ESR) and C Reaction Protein (CRP) are also to be tested, and these two inflammation indicators reflect the degree of activity of the disease, which generally increases significantly during RA activities, and are of great value in determining whether it is appropriate to activate the Adamu monotoxin and in subsequent evaluation of the efficacy of the drug.
Self-diagnostic tests: The antigens of rheumatism (RF) and cucumbers (CCP) are key indicators for the diagnosis and assessment of rheumatism. Most RA patients are positive and CCP antibodies are more specific to the diagnosis of the disease, often associated with the severity and prognosis of the disease. The diagnosis is further confirmed by the detection of these self-antibodies, and it also helps to observe changes in the follow-up treatment to measure disease control.
Hepatal and kidney function examination: A single anti-fatal response is mainly via liver and kidney metabolism. Pre-use knowledge of the patient ‘ s liver and kidney function is essential, such as the detection of indicators such as diarrhea enzymase, rhythmase, acetic anhydride, urea nitrogen, which may affect the metabolic and excretion of the drug on the one hand and, on the other hand, can increase the liver and kidney burden, leading to further impairment of the original function, so that the risk is known and assessed in advance.
Infectious disease screening: As biological agents may affect the immune function of the organism and increase the risk of infection, screening for infectious diseases such as hepatitis B, hepatitis C antibodies, antibodies for AIDS and syphilis-spirit antibodies is required before the use of Adam alone. In the case of patients with Hepatitis B surface anti-positive, special care must be taken and, where necessary, a combination of anti-Hepatitis B drugs should be used for preventive treatment in order to prevent the activation of the Hepatitis B virus in the course of the drug, which causes serious liver disease.
Video screening
X-line examination: The bone damage of the joint part, the narrow gap between the joints, etc. are clearly visible, are useful for the early detection of changes in small joints, such as the hand, wrist, and large joints, such as the knee, hip, etc., and determine the extent and extent of joint fatigue and provide an initial basis for subsequent comparison of the efficacy of the drug for the protection of the joint bone.
Magnetic resonance imaging (MRI) or ultrasound: MRI displays a clear picture of the soft tissue, slide membrane, bone marrow, etc., and detects early changes in arthromitis, osteoporosis, etc., and is more sensitive in assessing the extent of disease activity; ultrasound allows real-time observation of the growth of the mucularity, blood flow around the joint, as well as the presence of oscillitis, arthropod fluids, both of which are important for the diagnosis of the disease and for the follow-up monitoring of the efficacy of the drug treatment, especially at an early stage of the disease, where it may be possible that X-lines have not yet shown a significant bone modification, they better reflect the pathology of the joint.
